¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26
±³À°ÀÏÀÚ : 2021-03-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇѼҾƽÉÀåÇÐȸ
´ã´çÀÚ : ¼ÛÁø¿µ
¿¬¶ôó : 02-3410-0647  
À̸ÞÀÏ : pediheart@pediheart.or.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ (50,000) Àü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ (40,000) Çлý(¹«·á)      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:00~14:20 Nitric oxide revisit including iNOmax  Çϱâ¼ö(°í´ë±¸·Î º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:20~14:40 Riociguat in the pediatric population and clinical application  Á¤Á¶¿ø(¼¼ºê¶õ½º º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:40~15:00 IV Epoprestenol, preparation to use  ¾È°æÁø(±æ º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ15:00~15:20 Pulmonary vasodilator in Fontan patient, update  ±è±â¹ü(¼­¿ï´ë º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ15:20~15:40 Korean pulmonary hypertension guideline review  Â÷½½±â(¼­¿ï¾Æ»êº´¿ø) 
Åä·Ð 03¿ù 26ÀÏ ¿Â¶óÀΠ15:40~16:00 Åä·Ð  () 
È޽Ġ03¿ù 26ÀÏ  16:00~16:20 È޽Ġ () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:20~16:30 Overcome of pulmonary hypertension applying BiPAP for infant with lung hypoplasia  ±è¿©Çâ(°æºÏ´ë º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:30~16:40 ±¸¿¬2  °¡°­»ç(¼­¿ï¼º¸ð º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:40~16:50 ±¸¿¬3  ³ª°­»ç(¼­¿ï¾Æ»ê º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:50~17:00 ±¸¿¬4  ´Ù°­»ç(¼¼ºê¶õ½º º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ17:00~17:10 Successful treatment of subcutaneous treprostinil for pulmonary hypertension with bronchopulmonary dysplasia in an extremely premature infant  °íÈÆ(¾ç»ê ºÎ»ê´ë º´¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ17:10~17:20 ±¸¿¬6  ¶ó°­»ç(¼¼Á¾ º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѼҾƽÉÀåÇÐȸ (¿Â¶óÀÎ) ¼Ò¾ÆÆóµ¿¸Æ °íÇ÷¾Ð ½ÉÆ÷Áö¾ö : 2021-03-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦21ȸ ´ëÇÑÃéÀå´ãµµÇÐȸ È£³²Áöȸ ÇмúÁý´ãȸ : 2021-03-27
´ÙÀ½±Û ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) Á¦242Â÷ °æºÏÁöȸ Áý´ãȸ : 2021-03-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 62 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 85 2024-06-19
21120 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Çϰ迬¼ö°­Á : 2024-07-14 0 44 2024-06-19
21119 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (2ÀÏÂ÷) : 2024-07-13 0 59 2024-06-19
21118 ÀüºÏ 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Çϰ迬¼ö±³À° : 2024-07-13 0 60 2024-06-19
21117 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦1ȸ ´ç´¢¹ß ½ÉÆ÷Áö¾ö : 2024-07-13 0 29 2024-06-19
21116 ¼­¿ï õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13 0 32 2024-06-19
21115 ¼­¿ï 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13 0 59 2024-06-19
21114 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13 0 51 2024-06-19
21113 ¼­¿ï 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13 0 22 2024-06-19
21112 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12 0 22 2024-06-19
21111 ¼­¿ï 2024 ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ ÇÏ°è Çмú´ëȸ : 2024-07-12 0 28 2024-06-19
21110 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çϰ迬¼ö±³À° : 2024-07-12 0 52 2024-06-19
21109 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦5Â÷ Àå¾ÖÆÇÁ¤ ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2024-07-07 0 18 2024-06-19
21108 ¼­¿ï 2024³â ´ëÇѺñ´¢ºÎÀΰúÇÐȸ Á¦27Â÷ Çмú´ëȸ (¿ÀÇÁ¶óÀÎ) : 2024-07-07 0 50 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷